We are live on
!
Find out more
SCM
Solas Capital Management Portfolio holdings
AUM
$174M
1-Year Est. Return
6.33%
This Fund
S&P 500
This Quarter
Est. Return
-10.69%
1 Year Est. Return
+6.33%
3 Year Est. Return
+41.54%
5 Year Est. Return
+46.6%
10 Year Est. Return
–
AUM
$176M
AUM Growth
+$12.4M
(+7.6%)
Cap. Flow
+$32M
Cap. Flow
% of AUM
18.16%
Top 10 Holdings %
Top 10 Hldgs %
70.83%
Holding
26
New
6
Increased
8
Reduced
7
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kyndryl
KD
|
+$11.1M |
| 2 |
PRMB
Primo Brands
PRMB
|
+$8.51M |
| 3 |
Insperity
NSP
|
+$7.28M |
| 4 |
Euronet Worldwide
EEFT
|
+$5.73M |
| 5 |
Green Plains
GPRE
|
+$5.67M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$10.2M |
| 2 |
ZIMV
ZimVie
ZIMV
|
+$10M |
| 3 |
ODP
ODP
ODP
|
+$7.36M |
| 4 |
Bristow Group
VTOL
|
+$2.94M |
| 5 |
Sonida Senior Living
SNDA
|
+$361K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 39.49% |
| 2 | Materials | 13.47% |
| 3 | Consumer Staples | 10.71% |
| 4 | Energy | 9.33% |
| 5 | Technology | 9.32% |
Similar funds
BCP
LCWM
GWAM
VWWMG
GRA
CFS
CAM
AMD
Solas Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, Solas Capital Management held 26 positions worth $176M, up 7.6% from $164M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Solas Capital Management deployed $32M of net new capital in Q4 2025, opening 6 new positions and adding to 8 existing holdings. Its largest new stake was Kyndryl: 407,634 shares worth $10.8M.
By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 51% a quarter earlier, followed by Materials and Consumer Staples.
On the sell side, the largest reduction was Sonida Senior Living, an estimated $361K trimmed.
- Solas Capital Management's largest Q4 2025 buy was Kyndryl: 407,634 shares worth $10.8M.
- Solas Capital Management added most to Grocery Outlet in Q4 2025, an estimated $5.64M increase.
- Solas Capital Management's biggest Q4 2025 reduction was Sonida Senior Living, cutting an estimated $361K.
- Solas Capital Management fully exited Regeneron Pharmaceuticals in Q4 2025, selling an estimated $10.2M.
- Solas Capital Management's ten largest holdings make up 71% of its $176M portfolio in Q4 2025.
- Solas Capital Management opened 6 new positions and closed 4 in Q4 2025.
- Solas Capital Management's portfolio value rose 7.6% quarter-over-quarter to $176M.
Based on Solas Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.